ETF Objective

The Fund seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in emerging market countries. The Fund employs an indexing investment approach designed to track the FTSE Emerging Markets All Cap China A Inclusion Index by sampling the Index.

Stock Chart

as of 4:10 PM ET 10/18/2021


  • 1 Week
  • +2.13%
  • 1 Month
  • +0.54%
  • 3 Months
  • -2.38%
  • 1 Yr Return
  • +15.62%
  • 5 Yr Return
  • +36.45%

Sector Breakdown

Financials 21.77%
Technology 20.46%
Consumer Services 11.68%
Industrials 9.89%
Consumer Goods 9.70%
Basic Materials 8.36%
Oil & Gas 5.78%
Health Care 4.45%
Telecommunications 2.67%
Utilities 2.50%

Geographic Exposure

China 34.39%
Taiwan 18.04%
India 14.52%
Brazil 6.03%
South Africa 3.76%
Saudi Arabia 3.57%
Russian Federation 3.08%
Thailand 2.51%
Hong Kong 2.43%
Mexico 2.32%
Malaysia 1.94%
Indonesia 1.39%
Philippines 0.85%
United Arab Emirates 0.82%
Qatar 0.78%
Kuwait 0.66%
Turkey 0.55%
Chile 0.53%
Greece 0.32%
Hungary 0.28%
Colombia 0.22%
Unidentified 0.18%
Czech Republic 0.15%
Egypt 0.12%
United States 0.09%
Pakistan 0.08%
Cayman Islands 0.08%
Bahrain 0.07%
Singapore 0.05%
Isle of Man 0.04%
Romania 0.04%
Luxembourg 0.03%
Canada 0.02%
Australia 0.01%
Poland 0.01%
Netherlands 0.00%
Belgium 0.00%
Malta 0.00%

Top 10 Holdings

Symbol Company Name % Of Assets
TSM Taiwan Semiconductor Manufacturing Co Ltd DR 1.72%
INFY Infosys Ltd ORD 1.04%
VALE3 Vale SA ORD 0.82%
HDFC Housing Development Finance Corporation Ltd ORD 0.82%

ETF Overview

Sponsor Vanguard
iNav Ticker HVTM
Inception Date 03/04/2005
Name Vanguard EM St I;ETF
CUSIP 922042858
Prospectus Date 02/26/2021

ETF Characteristics

Market Capitalization 125.66 B
Total Net Assets 79.10 K
Management Fee 0.07%
Administration Fee 0.07%
Asset Class Equity
Sub Asset Class Emerging Markets Funds
Number Of Holdings 4,344
Expense Ratio 0.10
Dividend 0.82
Dividend Frequency Quarterly


Recent Articles from TheStreet

What to Watch Tuesday: Procter & Gamble Earnings, Inflation Data

Premarket Movers Tuesday - Procter & Gamble, Ulta, Netflix

Stocks moving in premarket trading include Procter & Gamble. Ulta, Netflix, Johnson & Johnson and Teladoc.

After Red-hot IPO, Chinese Biotech Firm Kintor Eyes Blockbuster Drugs For Prostate Cancer, Sex Hormone-related Hair Loss

Atea Pharma Stock Plunges After COVID Treatment Trial Disappoints; Merck Jumps

Atea Pharmaceuticals could shed more than $2 billion in value Tuesday after the drugmaker said a mid-stage trial of its developing COVID treatment failed to meet expectations.

What to know about Cloudflare's Upcoming IPO

Investing in the Cloud: Consider Cloudflare and Digital Ocean

Cloud-software growth stocks have been a bright spot in an uncertain market. Investors might look closely at Cloudflare and Digital Ocean.

Philip Morris International Lead

Philip Morris Ekes Out Third-Quarter Earnings Beat

Philip Morris posts a third-quarter earnings beat as sales of its smokeless non-tobacco products continue strong, though cautions on supply chain impact.

The Travelers Companies Lead

Travelers Posts Third Quarter Earnings Beat on Record Net Written Premiums

Travelers Companies posts third-quarter earnings that exceed analysts’ forecasts as a drop in what it calls ‘catastrophic losses’ offsets record net written premiums.

Lufax is set to make the biggest splash on the NYSE by a Chinese company since e-commerce giant Alibaba's IPO in 2014. Photo: Reuters

Stock Market Today: Dow Gains On Earnings Strength; Housing Starts Disappoint

Solid third quarters continue to power stocks higher Tuesday, even as growth and inflation signals remain stubbornly persistent as oil prices top $85 a barrel in overnight trading.

Procter & Gamble Is Under Siege From an Activist Investor

Procter & Gamble Stock Slips After Q1 Earnings Beat; 2022 Forecast Unchanged

Procter & Gamble held its 2022 forecasts in place, seeing sales growth of between 2% and 4%, following stronger-than-expected first quarter earnings.

No More Tears for Johnson & Johnson?

Johnson & Johnson Stock Gains as Vaccine Sales Boost Q3 Earnings, 2021 Forecasts

Johnson & Johnson said it sees 2021 vaccine sales of $2.5 billion, with overall revenues rising to between $94.1 billion to $94.6 billion, following its Q3 earnings beat.

Stock Market Lead

Stocks Gain, SEC GameStop Report, Rent The Runway IPO - 5 Things You Must Know

Stocks edge higher ahead of earnings; SEC says GameStop surge powered by believers; FDA set to approve "mix & match' COVID boosters; DraftKings faces Entain bid deadline and Rent the Runway seeks $1.3 billion valuation in Nasdaq IPO.